Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Immunopathogenesis of Asthma

천식의 면역학적 기전

  • Lee, Sang Yeub (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Korea University Anam Hospital) ;
  • In, Kwang Ho (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Korea University Anam Hospital)
  • 이상엽 (고려대학교 의과대학 내과학교실) ;
  • 인광호 (고려대학교 의과대학 내과학교실)
  • Published : 2006.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62 https://doi.org/10.1056/NEJM200102013440507
  2. Haley KJ, Sunday ME, Wiggs BR, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72 https://doi.org/10.1164/ajrccm.158.2.9705036
  3. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505-10 https://doi.org/10.1164/ajrccm.154.5.8912772
  4. Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157: 403-409 https://doi.org/10.1164/ajrccm.157.2.96-08040
  5. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-277 https://doi.org/10.1056/NEJM198902023200502
  6. Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000;97:43-49 https://doi.org/10.1006/clim.2000.4914
  7. Schwartz RS. A new element in the mechanism of asthma. N Engl J Med 2002;346:857-858 https://doi.org/10.1056/NEJM200203143461114
  8. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2004
  9. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261 https://doi.org/10.1126/science.282.5397.2258
  10. Bacharier LB, Jabara H, Geha RS. Molecular mechanisms of immunoglobulin E regulation. Int Arch Allergy Immunol 1998;115:257-269 https://doi.org/10.1159/000069456
  11. Siraganian RP. Biochemical events in basophil or mast cell activation and mediator release. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles & practice. 5th ed. Vol. 1. St. Louis: Mosby–Year Book, 1998:204-27
  12. Galli SJ. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med 1997;186:343-347 https://doi.org/10.1084/jem.186.3.343
  13. Lane SJ, Lee TH. Mast cell effector mechanisms. J Allergy Clin Immunol 1996;98:S67-S72 https://doi.org/10.1016/S0091-6749(96)70019-2
  14. Clark JM, Abraham WM, Fishman CE, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995;152:2076-2083 https://doi.org/10.1164/ajrccm.152.6.8520778
  15. Brandenburg AH, van Beek R, Moll HA, Osterhaus ADME, Claas ECJ. G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol 2000;38:3849-3852.
  16. Peters SP, Zangrilli JG, Fish JE. Late phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles & practice. 5th ed. Vol. 1. St. Louis: Mosby–Year Book, 1998:342-55
  17. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-3109
  18. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-1600 https://doi.org/10.1056/NEJM199805283382206
  19. Bochner BS. Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997;100:581-585 https://doi.org/10.1016/S0091-6749(97)70158-1
  20. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999;104:917-926 https://doi.org/10.1016/S0091-6749(99)70069-2
  21. Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol 1995;155:2194-2202
  22. Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 1998;161:971-977
  23. Hamid QA, Minshall EM. Molecular pathology of allergic disease. I. Lower airway disease. J Allergy Clin Immunol 2000;105:20-36 https://doi.org/10.1016/S0091-6749(00)90172-6
  24. Nakamura Y, Ghaffar O, Olivenstein R, et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999;103:215-222 https://doi.org/10.1016/S0091-6749(99)70493-8
  25. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304 https://doi.org/10.1056/NEJM199201303260504
  26. Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150:1038-1048 https://doi.org/10.1164/ajrccm.150.4.7921434
  27. Aubus P, Cosso B, Godard P, et al. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am Rev Respir Dis 1984;130:875-8
  28. Spiteri M, Knight RA, Jeremy JY, et al. Alveolar macrophage-induced suppression of T-cell hyperresponsiveness in bronchial asthma is reversed by allergen exposure. Eur Respir J 1994;7:1431-1438 https://doi.org/10.1183/09031936.94.07081431
  29. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857 https://doi.org/10.1136/thx.54.9.825
  30. Brewster CEP, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-511 https://doi.org/10.1165/ajrcmb/3.5.507
  31. Hirst SJ, Barnes PJ, Twort CHL. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am J Respir Cell Mol Biol 1992;7:574-581 https://doi.org/10.1165/ajrcmb/7.6.574
  32. Cerutis DR, Nogami M, Anderson JL, et al. Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol 1997;273:L10-L15
  33. Lynch KR, O'Neil GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789-93 https://doi.org/10.1038/21658
  34. Yokomizo T, Izumi T, Chang K, et al. A G-protein- coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997;387:620-4 https://doi.org/10.1038/42506
  35. Stafforini DM, Satoh K, Atkinson DL, et al. Platelet-activating factor acetylhydrolase deficiency : a missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 1996;97:2784-91 https://doi.org/10.1172/JCI118733
  36. Stafforini DM, Numao T, Tsodikov A, et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 1999; 103:989-97 https://doi.org/10.1172/JCI5574
  37. Levitt RC, McLane MP, MacDonald D, et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J. allergy Clin. Immunol. 1999; 103:s485-91.Holroyd KJ, Martinati LC, Trabetti E et al. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics. 1998; 52:233-5 https://doi.org/10.1006/geno.1998.5445
  38. McLane MP, Haczku A, van de Rijn M et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol. 1998;19:713-20 https://doi.org/10.1165/ajrcmb.19.5.3457
  39. Humbles AA, Lu B, Nilsson CA et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000; 161:998-1001 https://doi.org/10.1038/161998a0
  40. Karp CL, Grupe A, Schadt E et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 2000;1:221-6 https://doi.org/10.1038/79759
  41. Chalmers GW, Thomson L, Macleod KJ et al. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax 1997; 100: 544-52
  42. Redington AE, Springall DR, Ghatei MA et al. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy. Eur Respir J. 1997; 10: 1026-32 https://doi.org/10.1183/09031936.97.10051026
  43. Redington AE, Springall DR, Meng QH et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol. 1997; 100:544-52 https://doi.org/10.1016/S0091-6749(97)70148-9
  44. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun. 1991; 181:852-7 https://doi.org/10.1016/0006-291X(91)91268-H
  45. Kharitonov SA, Yates D, Robbins RA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343:133-5 https://doi.org/10.1016/S0140-6736(94)90931-8
  46. Massaro AF, Mehta S, Lilly CM et al. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996; 153:1510-14 https://doi.org/10.1164/ajrccm.153.5.8630594
  47. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998; 53:91-5 https://doi.org/10.1136/thx.53.2.91
  48. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998;12: 929-37 https://doi.org/10.1096/fasebj.12.11.929
  49. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336:1066-71 https://doi.org/10.1056/NEJM199704103361506
  50. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 1998: 158 :1585-92 https://doi.org/10.1164/ajrccm.158.5.9706116
  51. Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol. 1992; 213:331-6 https://doi.org/10.1016/0014-2999(92)90621-A
  52. Naseer T, Minshall EM, Leung DY et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997; 155:845-51 https://doi.org/10.1164/ajrccm.155.3.9117015
  53. Ho AS, Moore KW. Interleukin-10 and its receptor. Ther Immunol. 1994; 1:173-85
  54. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995; 270:9558-63 https://doi.org/10.1074/jbc.270.16.9558
  55. Borish L, Aarons A, Rumbyrt J et al. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996; 97:1288-96 https://doi.org/10.1016/S0091-6749(96)70197-5
  56. John M, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte- macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med.1998; 157:256-62 https://doi.org/10.1164/ajrccm.157.1.9703079
  57. Spiteri MA, Knight RA, Jeremy JY et al. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J. 1994; 7:1431-8 https://doi.org/10.1183/09031936.94.07081431
  58. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-344 https://doi.org/10.1056/NEJM200008033430506
  59. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-344 https://doi.org/10.1056/NEJM200008033430506
  60. Eisenbarth SC, Classel S, Bottomly K. Understanding asthma pathogenesis: linking innate and adaptive immunity. Current opinion in Pediatrics 2004; 16:659-665 https://doi.org/10.1097/01.mop.0000145920.00101.e4
  61. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevate release of tumor necrosis factor-$\alpha$ and interferon-$\gamma$ by bron-choalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147:291-295 https://doi.org/10.1164/ajrccm/147.2.291
  62. Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U, Holgate ST, Frew AJ, Howarth PH. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:319-326 https://doi.org/10.1165/ajrcmb.14.4.8600935
  63. Redecke V, Hacker H, Datta SK et al.: Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743 https://doi.org/10.4049/jimmunol.172.5.2739
  64. Walter MJ, Holtzman MJ. A centennial history of research on asthma pathogenesis. Am J Respir Cell Mol Biol 2005; 32:483-489 https://doi.org/10.1165/rcmb.F300